Copyright Reports & Markets. All rights reserved.

Global and United States Allograft Demineralized Bone Matrix Market Report & Forecast 2022-2028

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Allograft Demineralized Bone Matrix Product Introduction
    • 1.2 Global Allograft Demineralized Bone Matrix Outlook 2017 VS 2022 VS 2028
      • 1.2.1 Global Allograft Demineralized Bone Matrix Sales in US$ Million for the Year 2017-2028
      • 1.2.2 Global Allograft Demineralized Bone Matrix Sales in Volume for the Year 2017-2028
    • 1.3 United States Allograft Demineralized Bone Matrix Outlook 2017 VS 2022 VS 2028
      • 1.3.1 United States Allograft Demineralized Bone Matrix Sales in US$ Million for the Year 2017-2028
      • 1.3.2 United States Allograft Demineralized Bone Matrix Sales in Volume for the Year 2017-2028
    • 1.4 Allograft Demineralized Bone Matrix Market Size, United States VS Global, 2017 VS 2022 VS 2028
      • 1.4.1 The Market Share of United States Allograft Demineralized Bone Matrix in Global, 2017 VS 2022 VS 2028
      • 1.4.2 The Growth Rate of Allograft Demineralized Bone Matrix Market Size, United States VS Global, 2017 VS 2022 VS 2028
    • 1.5 Allograft Demineralized Bone Matrix Market Dynamics
      • 1.5.1 Allograft Demineralized Bone Matrix Industry Trends
      • 1.5.2 Allograft Demineralized Bone Matrix Market Drivers
      • 1.5.3 Allograft Demineralized Bone Matrix Market Challenges
      • 1.5.4 Allograft Demineralized Bone Matrix Market Restraints
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Market by Type

    • 2.1 Allograft Demineralized Bone Matrix Market Segment by Type
      • 2.1.1 Gel
      • 2.1.2 Putty
      • 2.1.3 Putty with Chips
      • 2.1.4 Others
    • 2.2 Global Allograft Demineralized Bone Matrix Market Size by Type
      • 2.2.1 Global Allograft Demineralized Bone Matrix Sales in Value, by Type (2017, 2022 & 2028)
      • 2.2.2 Global Allograft Demineralized Bone Matrix Sales in Volume, by Type (2017, 2022 & 2028)
      • 2.2.3 Global Allograft Demineralized Bone Matrix Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    • 2.3 United States Allograft Demineralized Bone Matrix Market Size by Type
      • 2.3.1 United States Allograft Demineralized Bone Matrix Sales in Value, by Type (2017, 2022 & 2028)
      • 2.3.2 United States Allograft Demineralized Bone Matrix Sales in Volume, by Type (2017, 2022 & 2028)
      • 2.3.3 United States Allograft Demineralized Bone Matrix Average Selling Price (ASP) by Type (2017, 2022 & 2028)

    3 Market by Application

    • 3.1 Allograft Demineralized Bone Matrix Market Segment by Application
      • 3.1.1 Dental
      • 3.1.2 Spine Surgery
      • 3.1.3 Trauma Surgery
    • 3.2 Global Allograft Demineralized Bone Matrix Market Size by Application
      • 3.2.1 Global Allograft Demineralized Bone Matrix Sales in Value, by Application (2017, 2022 & 2028)
      • 3.2.2 Global Allograft Demineralized Bone Matrix Sales in Volume, by Application (2017, 2022 & 2028)
      • 3.3.3 Global Allograft Demineralized Bone Matrix Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    • 3.3 United States Allograft Demineralized Bone Matrix Market Size by Application
      • 3.3.1 United States Allograft Demineralized Bone Matrix Sales in Value, by Application (2017, 2022 & 2028)
      • 3.3.2 United States Allograft Demineralized Bone Matrix Sales in Volume, by Application (2017, 2022 & 2028)
      • 3.3.3 United States Allograft Demineralized Bone Matrix Average Selling Price (ASP) by Application (2017, 2022 & 2028)

    4 Global Allograft Demineralized Bone Matrix Competitor Landscape by Company

    • 4.1 Global Allograft Demineralized Bone Matrix Market Size by Company
      • 4.1.1 Top Global Allograft Demineralized Bone Matrix Manufacturers Ranked by Revenue (2021)
      • 4.1.2 Global Allograft Demineralized Bone Matrix Revenue by Manufacturer (2017-2022)
      • 4.1.3 Global Allograft Demineralized Bone Matrix Sales by Manufacturer (2017-2022)
      • 4.1.4 Global Allograft Demineralized Bone Matrix Price by Manufacturer (2017-2022)
    • 4.2 Global Allograft Demineralized Bone Matrix Concentration Ratio (CR)
      • 4.2.1 Allograft Demineralized Bone Matrix Market Concentration Ratio (CR) (2017-2022)
      • 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Allograft Demineralized Bone Matrix in 2021
      • 4.2.3 Global Allograft Demineralized Bone Matrix Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 4.3 Global Allograft Demineralized Bone Matrix Manufacturing Base Distribution, Product Type
      • 4.3.1 Global Allograft Demineralized Bone Matrix Manufacturers, Headquarters and Distribution of Producing Region
      • 4.3.2 Manufacturers Allograft Demineralized Bone Matrix Product Type
      • 4.3.3 Date of International Manufacturers Enter into Allograft Demineralized Bone Matrix Market
    • 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    • 4.5 United States Allograft Demineralized Bone Matrix Market Size by Company
      • 4.5.1 Top Allograft Demineralized Bone Matrix Players in United States, Ranked by Revenue (2021)
      • 4.5.2 United States Allograft Demineralized Bone Matrix Revenue by Players (2020, 2021 & 2022)
      • 4.5.3 United States Allograft Demineralized Bone Matrix Sales by Players (2020, 2021 & 2022)

    5 Global Allograft Demineralized Bone Matrix Market Size by Region

    • 5.1 Global Allograft Demineralized Bone Matrix Market Size by Region: 2017 VS 2022 VS 2028
    • 5.2 Global Allograft Demineralized Bone Matrix Market Size in Volume by Region (2017-2028)
      • 5.2.1 Global Allograft Demineralized Bone Matrix Sales in Volume by Region: 2017-2022
      • 5.2.2 Global Allograft Demineralized Bone Matrix Sales in Volume Forecast by Region (2023-2028)
    • 5.3 Global Allograft Demineralized Bone Matrix Market Size in Value by Region (2017-2028)
      • 5.3.1 Global Allograft Demineralized Bone Matrix Sales in Value by Region: 2017-2022
      • 5.3.2 Global Allograft Demineralized Bone Matrix Sales in Value by Region: 2023-2028

    6 Segment in Region Level & Country Level

    • 6.1 North America
      • 6.1.1 North America Allograft Demineralized Bone Matrix Market Size YoY Growth 2017-2028
      • 6.1.2 North America Allograft Demineralized Bone Matrix Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.1.3 United States
      • 6.1.4 Canada
    • 6.2 Asia-Pacific
      • 6.2.1 Asia-Pacific Allograft Demineralized Bone Matrix Market Size YoY Growth 2017-2028
      • 6.2.2 Asia-Pacific Allograft Demineralized Bone Matrix Market Facts & Figures by Region (2017, 2022 & 2028)
      • 6.2.3 China
      • 6.2.4 Japan
      • 6.2.5 South Korea
      • 6.2.6 India
      • 6.2.7 Australia
      • 6.2.8 China Taiwan
      • 6.2.9 Indonesia
      • 6.2.10 Thailand
      • 6.2.11 Malaysia
    • 6.3 Europe
      • 6.3.1 Europe Allograft Demineralized Bone Matrix Market Size YoY Growth 2017-2028
      • 6.3.2 Europe Allograft Demineralized Bone Matrix Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.3.3 Germany
      • 6.3.4 France
      • 6.3.5 U.K.
      • 6.3.6 Italy
      • 6.3.7 Russia
    • 6.4 Latin America
      • 6.4.1 Latin America Allograft Demineralized Bone Matrix Market Size YoY Growth 2017-2028
      • 6.4.2 Latin America Allograft Demineralized Bone Matrix Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.4.3 Mexico
      • 6.4.4 Brazil
      • 6.4.5 Argentina
    • 6.5 Middle East and Africa
      • 6.5.1 Middle East and Africa Allograft Demineralized Bone Matrix Market Size YoY Growth 2017-2028
      • 6.5.2 Middle East and Africa Allograft Demineralized Bone Matrix Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.5.3 Turkey
      • 6.5.4 Saudi Arabia
      • 6.5.5 UAE

    7 Company Profiles

    • 7.1 Medtronic
      • 7.1.1 Medtronic Corporation Information
      • 7.1.2 Medtronic Description and Business Overview
      • 7.1.3 Medtronic Allograft Demineralized Bone Matrix Sales, Revenue and Gross Margin (2017-2022)
      • 7.1.4 Medtronic Allograft Demineralized Bone Matrix Products Offered
      • 7.1.5 Medtronic Recent Development
    • 7.2 J &J (DePuy Synthes)
      • 7.2.1 J &J (DePuy Synthes) Corporation Information
      • 7.2.2 J &J (DePuy Synthes) Description and Business Overview
      • 7.2.3 J &J (DePuy Synthes) Allograft Demineralized Bone Matrix Sales, Revenue and Gross Margin (2017-2022)
      • 7.2.4 J &J (DePuy Synthes) Allograft Demineralized Bone Matrix Products Offered
      • 7.2.5 J &J (DePuy Synthes) Recent Development
    • 7.3 SeaSpine
      • 7.3.1 SeaSpine Corporation Information
      • 7.3.2 SeaSpine Description and Business Overview
      • 7.3.3 SeaSpine Allograft Demineralized Bone Matrix Sales, Revenue and Gross Margin (2017-2022)
      • 7.3.4 SeaSpine Allograft Demineralized Bone Matrix Products Offered
      • 7.3.5 SeaSpine Recent Development
    • 7.4 Xtant Medical
      • 7.4.1 Xtant Medical Corporation Information
      • 7.4.2 Xtant Medical Description and Business Overview
      • 7.4.3 Xtant Medical Allograft Demineralized Bone Matrix Sales, Revenue and Gross Margin (2017-2022)
      • 7.4.4 Xtant Medical Allograft Demineralized Bone Matrix Products Offered
      • 7.4.5 Xtant Medical Recent Development
    • 7.5 Zimmer Biomet
      • 7.5.1 Zimmer Biomet Corporation Information
      • 7.5.2 Zimmer Biomet Description and Business Overview
      • 7.5.3 Zimmer Biomet Allograft Demineralized Bone Matrix Sales, Revenue and Gross Margin (2017-2022)
      • 7.5.4 Zimmer Biomet Allograft Demineralized Bone Matrix Products Offered
      • 7.5.5 Zimmer Biomet Recent Development
    • 7.6 Stryker
      • 7.6.1 Stryker Corporation Information
      • 7.6.2 Stryker Description and Business Overview
      • 7.6.3 Stryker Allograft Demineralized Bone Matrix Sales, Revenue and Gross Margin (2017-2022)
      • 7.6.4 Stryker Allograft Demineralized Bone Matrix Products Offered
      • 7.6.5 Stryker Recent Development
    • 7.7 Straumann
      • 7.7.1 Straumann Corporation Information
      • 7.7.2 Straumann Description and Business Overview
      • 7.7.3 Straumann Allograft Demineralized Bone Matrix Sales, Revenue and Gross Margin (2017-2022)
      • 7.7.4 Straumann Allograft Demineralized Bone Matrix Products Offered
      • 7.7.5 Straumann Recent Development
    • 7.8 Wright Medical Group
      • 7.8.1 Wright Medical Group Corporation Information
      • 7.8.2 Wright Medical Group Description and Business Overview
      • 7.8.3 Wright Medical Group Allograft Demineralized Bone Matrix Sales, Revenue and Gross Margin (2017-2022)
      • 7.8.4 Wright Medical Group Allograft Demineralized Bone Matrix Products Offered
      • 7.8.5 Wright Medical Group Recent Development
    • 7.9 Hans Biomed
      • 7.9.1 Hans Biomed Corporation Information
      • 7.9.2 Hans Biomed Description and Business Overview
      • 7.9.3 Hans Biomed Allograft Demineralized Bone Matrix Sales, Revenue and Gross Margin (2017-2022)
      • 7.9.4 Hans Biomed Allograft Demineralized Bone Matrix Products Offered
      • 7.9.5 Hans Biomed Recent Development
    • 7.10 Arthrex
      • 7.10.1 Arthrex Corporation Information
      • 7.10.2 Arthrex Description and Business Overview
      • 7.10.3 Arthrex Allograft Demineralized Bone Matrix Sales, Revenue and Gross Margin (2017-2022)
      • 7.10.4 Arthrex Allograft Demineralized Bone Matrix Products Offered
      • 7.10.5 Arthrex Recent Development

    8 Industry Chain and Sales Channels Analysis

    • 8.1 Allograft Demineralized Bone Matrix Industry Chain Analysis
    • 8.2 Allograft Demineralized Bone Matrix Key Raw Materials
      • 8.2.1 Key Raw Materials
      • 8.2.2 Allograft Demineralized Bone Matrix Distributors
    • 8.3 Allograft Demineralized Bone Matrix Production Mode & Process
    • 8.4 Allograft Demineralized Bone Matrix Sales and Marketing
      • 8.4.1 Allograft Demineralized Bone Matrix Sales Channels
      • 8.4.2 Allograft Demineralized Bone Matrix Distributors
    • 8.5 Allograft Demineralized Bone Matrix Customers

    9 Research Findings and Conclusion

      10 Appendix

      • 10.1 Research Methodology
        • 10.1.1 Methodology/Research Approach
        • 10.1.2 Data Source
      • 10.2 Author Details

      Summary:

      Demineralized bone matrix (DBM) is allograft bone that has had the inorganic mineral removed, leaving behind the organic "collagen" matrix.
      Market Analysis and Insights: Global and United States Allograft Demineralized Bone Matrix Market
      This report focuses on global and United States Allograft Demineralized Bone Matrix market, also covers the segmentation data of other regions in regional level and county level.
      Due to the COVID-19 pandemic, the global Allograft Demineralized Bone Matrix market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, Gel accounting for % of the Allograft Demineralized Bone Matrix global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Dental was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
      In United States the Allograft Demineralized Bone Matrix market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.
      Global Allograft Demineralized Bone Matrix Scope and Market Size
      Allograft Demineralized Bone Matrix market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Allograft Demineralized Bone Matrix market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
      For United States market, this report focuses on the Allograft Demineralized Bone Matrix market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
      Segment by Type, the Allograft Demineralized Bone Matrix market is segmented into
      Gel
      Putty
      Putty with Chips
      Others
      Segment by Application, the Allograft Demineralized Bone Matrix market is segmented into
      Dental
      Spine Surgery
      Trauma Surgery
      Regional and Country-level Analysis
      By Region
      North America
      United States
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      China Taiwan
      Indonesia
      Thailand
      Malaysia
      Latin America
      Mexico
      Brazil
      Argentina
      Middle East & Africa
      Turkey
      Saudi Arabia
      UAE
      Competitive Landscape and Allograft Demineralized Bone Matrix Market Share Analysis
      Allograft Demineralized Bone Matrix market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Allograft Demineralized Bone Matrix business, the date to enter into the Allograft Demineralized Bone Matrix market, Allograft Demineralized Bone Matrix product introduction, recent developments, etc.
      The major vendors covered:
      Medtronic
      J &J (DePuy Synthes)
      SeaSpine
      Xtant Medical
      Zimmer Biomet
      Stryker
      Straumann
      Wright Medical Group
      Hans Biomed
      Arthrex
      Buy now